Ameriflex Group, Inc. Halozyme Therapeutics, Inc. Transaction History

Ameriflex Group, Inc.

  • $218 Billion
  • Q4 2024

A detailed history of Ameriflex Group, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Ameriflex Group, Inc. holds 500 shares of HALO stock, worth $28,875. This represents 0.01% of its overall portfolio holdings.

Number of Shares
500
Holding current value
$28,875
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 24, 2025
BUY
$42.57 - $61.09 $21,285 - $30,545
500 New
500 $28.3 Million

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.04B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Ameriflex Group, Inc. Portfolio

Follow Ameriflex Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriflex Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameriflex Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email